Yutaka Takaoka

Prof. Dr. Yutaka Takaoka

University of Toyama, Toyama, Japan
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
TYTomohiko Yamamura
Tomohiko Yamamura
THTomoko Horinouchi
Tomoko Horinouchi
TATomomi Adachi
Tomomi Adachi
MTMaki Terakawa
Maki Terakawa
YTYutaka Takaoka
Yutaka Takaoka
KNKandai Nozu
Kandai Nozu
Currently, there are no treatments for Alport syndrome, which is the second most commonly inherited kidney disease. Here we report the development of an exon-skipping therapy using an antisense-oligonucleotide (ASO) for severe male X-linked Alport syndrome (XLAS). We targeted truncating variants in exon 21 of the COL4A5 gene and conducted a type IV collagen α3/α4/α5 chain triple helix formation assay, and in vitro and in vivo treatment efficacy evaluation. We show that exon skipping enabled trimer formation, leading to remarkable clinical and pathological improvements including expression of the α5 chain on glomerular and the tubular basement membrane. In addition, the survival period was clearly prolonged in the ASO treated mice group. This data suggests that exon skipping may represent a promising therapeutic approach for treating severe male XLAS cases.

8 June 2023 in Nature Genetics
Verified
Journal Article
Open access
PDF file
XWXilin Wu
Xilin Wu
EAElena Aisha Azizan
Elena Aisha Azizan
EGEmily Goodchild
Emily Goodchild
SGSumedha Garg
Sumedha Garg
MHMan Hagiyama
Man Hagiyama
MBMorris J. Brown
Morris J. Brown
Aldosterone-producing adenomas (APAs) are the commonest curable cause of hypertension. Most have gain-of-function somatic mutations of ion channels or transporters. Herein we report the discovery, replication and phenotype of mutations in the neuronal cell adhesion gene CADM1. Independent whole exome sequencing of 40 and 81 APAs found intramembranous p.Val380Asp or p.Gly379Asp variants in two patients whose hypertension and periodic primary aldosteronism were cured by adrenalectomy. Replication identified two more APAs with each variant (total, n = 6). The most upregulated gene (10- to 25-fold) in human adrenocortical H295R cells transduced with the mutations (compared to wildtype) was CYP11B2 (aldosterone synthase), and biological rhythms were the most differentially expressed process. CADM1 knockdown or mutation inhibited gap junction (GJ)-permeable dye transfer. GJ blockade by Gap27 increased CYP11B2 similarly to CADM1 mutation. Human adrenal zona glomerulosa (ZG) expression of GJA1 (the main GJ protein) was patchy, and annular GJs (sequelae of GJ communication) were less prominent in CYP11B2-positive micronodules than adjacent ZG. Somatic mutations of CADM1 cause reversible hypertension and reveal a role for GJ communication in suppressing physiological aldosterone production.

1 January 2012 in Frontiers in Physiology
Verified
Journal Article
Open access
MOMasaki Ohmuraya
Masaki Ohmuraya
ASAki Sugano
Aki Sugano
MHMasahiko Hirota
Masahiko Hirota
YTYutaka Takaoka
Yutaka Takaoka
KYKen-Ichi Yamamura
Ken-Ichi Yamamura
Studies on hereditary pancreatitis have provided evidence in favor of central role for trypsin activity in the disease. Identification of genetic variants of trypsinogen linked the protease to the onset of pancreatitis, and biochemical characterization proposed an enzymatic gain of function as the initiating mechanism. Mutations of serine protease inhibitor Kazal type 1 gene (SPINK1) are shown to be associated with hereditary pancreatitis. We previously reported that Spink3 (a mouse homolog gene of human SPINK1) deficient mice showed excessive autophagy, followed by inappropriate trypsinogen activation in the exocrine pancreas. These data indicate that the role of SPINK1/Spink3 is not only trypsin inhibitor, but also negative regulator of autophagy. On the other hand, recent studies showed that high levels of SPINK1 protein detected in a serum or urine were associated with adverse outcome in various cancer types. It has been suggested that expression of SPINK1 and trypsin is balanced in normal tissue, but this balance could be disrupted during tumor progression. Based on the structural similarity between SPINK1 and epidermal growth factor (EGF), we showed that SPINK1 protein binds and activates EGF receptor, thus acting as a growth factor on tumor cell lines. In this review, we summarize the old and new roles of SPINK1/Spink3 in trypsin inhibition, autophagy, and cancer cell growth. These new functions of SPINK1/Spink3 may be related to the development of chronic pancreatitis.

31 December 2020 in Kidney Research and Clinical Practice
Verified
Journal Article
Open access
PDF file
KNKandai Nozu
Kandai Nozu
YTYutaka Takaoka
Yutaka Takaoka
HKHirofumi Kai
Hirofumi Kai
MTMinoru Takasato
Minoru Takasato
KYKensuke Yabuuchi
Kensuke Yabuuchi
KIKazumoto Iijima
Kazumoto Iijima
Kandai Nozu, Yutaka Takaoka, Hirofumi Kai, Minoru Takasato, Kensuke Yabuuchi, Tomohiko Yamamura, Tomoko Horinouchi, Nana Sakakibara, Takeshi Ninchoji, China Nagano, Kazumoto Iijima. Kidney Research and Clinical Practice 2020;39:402-13. https://doi.org/10.23876/j.krcp.20.111

1 November 1994 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
YTYutaka Takaoka
Yutaka Takaoka
HIHiroshi Ideguchi
Hiroshi Ideguchi
MMMiho Matsuda
Miho Matsuda
NSNorihiro Sakamoto
Norihiro Sakamoto
TTTakayuki Takeuchi
Takayuki Takeuchi
YFYasuyuki Fukumaki
Yasuyuki Fukumaki

29 December 2017 in Transgenic Research
Verified
Journal Article
Open access
PDF file
MOMika Ohta
Mika Ohta
ASAki Sugano
Aki Sugano
NHNaoya Hatano
Naoya Hatano
HSHirotaka Sato
Hirotaka Sato
HSHirofumi Shimada
Hirofumi Shimada
YTYutaka Takaoka
Yutaka Takaoka
The disease model of familial amyloidotic polyneuropathy—7.2-hMet30 mice—manifests amyloid deposition that consists of a human amyloidogenic mutant transthyretin (TTR) (TTR V30M). Our previous study found amyloid deposits in 14 of 27 7.2-hMet30 mice at 21–24 months of age. In addition, non-fibrillar TTR deposits were found in amyloid-negative 7.2hMet30 mice. These results suggested that TTR amyloidogenesis required not only mutant TTR but also an additional factor (or factors) as an etiologic molecule. To determine the differences in serum proteome in amyloid-positive and amyloid-negative mice in the 7.2-hMet30 model, we used proteomic analyses and studied serum samples obtained from these mice. Hemopexin (HPX) and transferrin (Tf) were detected in the serum samples from amyloid-positive mice and were also found in amyloid deposits via immunohistochemistry, but serum samples from amyloid-negative mice did not contain HPX and Tf. These two proteins were also not detected in non-fibrillar TTR deposits. In addition, in silico analyses suggested that HPX and Tf facilitate destabilization of TTR secondary structures and misfolding of TTR. These results suggest that HPX and Tf may be associated with TTR amyloidogenesis after fibrillogenesis in vivo.